Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22571355&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Mol+Pain 2012 ; 8 (?): 36 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation #MMPMID22571355
Gavva NR; Davis C; Lehto SG; Rao S; Wang W; Zhu DX
Mol Pain 2012[May]; 8 (?): 36 PMID22571355show ga
BACKGROUND: Transient receptor potential cation channel subfamily M member 8 (TRPM8) is activated by cold temperature in vitro and has been demonstrated to act as a 'cold temperature sensor' in vivo. Although it is known that agonists of this 'cold temperature sensor', such as menthol and icilin, cause a transient increase in body temperature (Tb), it is not known if TRPM8 plays a role in Tb regulation. Since TRPM8 has been considered as a potential target for chronic pain therapeutics, we have investigated the role of TRPM8 in Tb regulation. RESULTS: We characterized five chemically distinct compounds (AMG0635, AMG2850, AMG8788, AMG9678, and Compound 496) as potent and selective antagonists of TRPM8 and tested their effects on Tb in rats and mice implanted with radiotelemetry probes. All five antagonists used in the study caused a transient decrease in Tb (maximum decrease of 0.98 degrees C). Since thermoregulation is a homeostatic process that maintains Tb about 37 degrees C, we further evaluated whether repeated administration of an antagonist attenuated the decrease in Tb. Indeed, repeated daily administration of AMG9678 for four consecutive days showed a reduction in the magnitude of the Tb decrease Day 2 onwards. CONCLUSIONS: The data reported here demonstrate that TRPM8 channels play a role in Tb regulation. Further, a reduction of magnitude in Tb decrease after repeated dosing of an antagonist suggests that TRPM8's role in Tb maintenance may not pose an issue for developing TRPM8 antagonists as therapeutics.
|*Body Temperature Regulation/drug effects[MESH]
|Animals[MESH]
|CHO Cells[MESH]
|Cricetinae[MESH]
|Dose-Response Relationship, Drug[MESH]
|Inhibitory Concentration 50[MESH]
|Ion Channel Gating/drug effects[MESH]
|Male[MESH]
|Membrane Transport Modulators/chemistry/pharmacology[MESH]
free
free
free
Mol+Pain 2012 ; 8 (?): 36
